Chief Medical Officer · Immix Biopharma, Inc. (IMMX)

Graham Ross

A named executive officer of Immix Biopharma in every fiscal year CompBrief holds from FY2023 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$88,593

Salary $88,593Stock awards $0

FY2023: $156,635

3rd of 3 named executive officers at Immix Biopharma by FY2024 total.

3 named officers on file for Immix Biopharma, FY2024

Graham Ross’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Immix Biopharma’s whole pay program stands against its peers

  • Immix Biopharma’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IMMX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2025 (DEF 14A).

Free

Get Graham Ross’s full pay file as a PDF — free

More than this page: up to 10 years of Graham’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Graham Ross compensation by year

Immix Biopharma Summary Compensation Table · all 2 fiscal years held
In US dollars, as Immix Biopharma reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024
Salary$104,423$88,593
Bonus—$0
Stock awards$0$0
Option awards$0—
Non-equity incentive$52,212$0
Pension and deferred compensation$0$0
All other$0$0
Total$156,635$88,593

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Immix Biopharma, Inc. DEF 14A filed April 30, 2025, accession 0001641172-25-006711, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Immix Biopharma, Inc. filed document, accession 0001641172-25-006711. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2025.

$157K
$89K
FY23
FY24
SalaryNon-equity incentive

Immix Biopharma’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Gabriel MorrisChief Financial Officer$1,267,158
Ilya RachmanChief Executive Officer$1,267,158
Graham Ross · this pageChief Medical Officer$88,593

The full Immix Biopharma compensation record

free company brief

This page is one person within Immix Biopharma's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Immix Biopharma's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Graham Ross's compensation dossier · One-time report. No refunds.